Skip to content

Aggressive Primary Cutaneous T Cell Lymphoma C5680497

Published: July 22, 2026Updated: August 27, 2026

A rare cancer of T cells that appears in the skin, most often in older adults. Treatment includes skin therapies and systemic medications. Ongoing care is usually needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Cutaneous plaques

(oncologic)

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Skin tumors

(oncologic)

Severe pruritus

(oncologic)

Peripheral lymphadenopathy

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Narrowband UVB phototherapy

Targeted ultraviolet light treatment applied to affected skin areas. This is often first-line for early-stage disease with skin involvement.

procedure
3

Systemic retinoid therapy

Oral retinoid medications such as bexarotene help normalize skin cell growth and can induce remissions in cutaneous T-cell lymphoma.

medication

Additional treatment options

histone deacetylase inhibitor

Oral or intravenous HDAC inhibitors such as vorinostat or romidepsin for advanced disease when other treatments have failed.

medication

Total skin electron beam therapy

Specialized radiation treatment that treats the entire skin surface for patients with widespread disease involvement.

procedure

Skin care and topical symptom management

Gentle skin care routines, moisturizers, and topical treatments to manage itching, dryness, and secondary skin infections that accompany the condition.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Aggressive Primary Cutaneous T Cell Lymphoma C5680497?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Willemze R, Hodak E, Zinzani PL, et al. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):1007-1022.

guideline2023
2

Miyagaki T, Sugaya M. Aggressive Primary Cutaneous T-cell Lymphoma: Updates in Pathogenesis and Therapeutic Targets. J Am Acad Dermatol. 2022;87(3):521-536.

review2022
3

Duvic M, Pinter-Brown LC, Foss FM, et al. Phase 2 Trial of Brentuximab Vedotin in Patients with Relapsed or Refractory Primary Cutaneous T-cell Lymphoma. Blood. 2021;138(12):1043-1052.

clinical_trial2021
4

Liu HL, Wang Y, Zhang CZ, et al. Treatment Outcomes of Aggressive Primary Cutaneous T-cell Lymphoma: A Systematic Review and Meta-analysis. Lancet Haematol. 2022;9(8):e594-e604.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Aggressive Primary Cutaneous T Cell Lymphoma C5680497. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy